Abundant anti-apoptotic BCL-2 is a molecular target in leukaemias with t(4;11) translocation

Blaine W. Robinson, Kathryn C. Behling, Manish Gupta, Alena Y. Zhang, Jonni S. Moore, Andrew D. Bantly, Cheryl L. Willman, Andrew J. Carroll, Peter C. Adamson, Jeffrey S. Barrett, Carolyn A. Felix

Research output: Contribution to journalArticlepeer-review

47 Scopus citations

Fingerprint

Dive into the research topics of 'Abundant anti-apoptotic BCL-2 is a molecular target in leukaemias with t(4;11) translocation'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science